However, compared with the control group, there was a significant increase in body mass index (BMI), luteinizing hormone (LH), testosterone (T), dehydroepiandrosterone (DHEA-s), and anti-Mullerian hormone (AMH), but a decline in follicle-stimulating hormone (FSH) in the PCOS group (p < 0.05) as expected, which is due to the clinical features of PCOS. Here, PLOD1 is linked to polycystic ovary syndrome.